Dr. Anil Patri | CureTalks
Dr. Anil K. Patri is Deputy Director at Nanotechnology Characterization Laboratory (NCL) at the National Cancer Institute, Frederick. At NCL, team of scientists from multidisciplinary fields are working together to facilitate the development of nanomaterials intended for clinical use. Dr. Patri is involved in physico-chemical characterization and standardization of nanomaterials for the NCL and collaborates with scientists at National Institute of Standards and Technology (NIST) and Food and Drug Administration (FDA). Prior to joining NCL, he was working as Staff Scientist at Center for Biologic Nanotechnology at University of Michigan, where he developed dendrimers based nanomaterials for targeting, imaging and drug delivery applications. Dr. Patri received his Ph.D. in Organic Chemistry from University of South Florida, M.Sc. in Organic Chemistry from Aligarh Muslim University, and B.Sc. in Organic Chemistry from Osmania University, India.
Nanotechnology in Oncology
What is nanotechnology and how is this field of technology revolutionizing drug delivery and cancer treatment approach? The Director of National Cancer Institute…